Seeking Alpha

Reckitt Benckiser: Spinning off pharma division a strong option

  • Reckitt Benckiser (RBGLY) could spin off its declining pharmaceuticals operations, saying that the idea is "emerging as a strong option." However, selling the business or even keeping it are still possible.
  • The division's net sales dropped 15% in Q1 to £170M.
  • Total net revenues declined 6% to £2.37B.
  • Shares are +0.3% in London. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector